ArticleCureus2025
Trends and Outcomes of Lower Limb Amputation in Patients With Coronary Artery Disease.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and aim Coronary artery disease (CAD) is a leading cause of morbidity and mortality in the United States, with peripheral arterial disease (PAD) and lower limb (LL) amputation contributing to poor cardiovascular outcomes. While previous studies have identified the link between CAD and PAD-related amputations, data on short-term in-hospital outcomes remain limited. This study aimed to compare in-hospital mortality and complications between CAD patients undergoing LL amputation and those without it. Methods We conducted a retrospective cohort study using the Nationwide Inpatient Sample (NIS) from 2016 to 2021, identifying CAD patients with and without LL amputation via International Classification of Diseases, 10th Revision (ICD-10) codes. Propensity score matching (PSM) was performed using a 1:1 nearest-neighbor algorithm to minimize selection bias, adjusting for demographics, comorbidities, and hospital characteristics. The primary outcome was in-hospital all-cause mortality, while secondary outcomes included acute heart failure, cardiogenic shock, acute kidney injury (AKI), major adverse cardiac and cerebrovascular events (MACCE), and healthcare resource utilization. Results A total of 31,379,939 CAD patients were identified, with 119,320 (0.4%) undergoing LL amputation. After propensity score matching (PSM), 23,261 patients were included in each group. The LL amputation cohort exhibited significantly higher in-hospital mortality (5.5% vs. 3.3%, p<0.001), cardiac arrest (2.3% vs. 1.4%, p<0.001), acute kidney injury (AKI) (29.3% vs. 26.8%, p<0.001), and acute limb ischemia (5.2% vs. 0.4%, p<0.001). Conversely, CAD patients without amputation had higher rates of acute heart failure (18.3% vs. 10.7%, p<0.001), major adverse cardiac and cerebrovascular events (MACCE) (22.5% vs. 12.2%, p<0.001), and percutaneous coronary intervention (6.7% vs. 0.9%, p<0.001). The length of stay and total hospital charges were significantly higher in the amputation group (10 days vs. four days; $26,590 vs. $11,686, p<0.001). Conclusion Lower limb amputation in CAD patients is associated with increased in-hospital mortality, cardiac complications, and healthcare resource utilization. These findings underscore the need for early intervention strategies targeting PAD progression and comprehensive perioperative cardiovascular risk management in amputees. Future research should focus on optimizing revascularization approaches, rehabilitation programs, and tailored preventive measures to improve outcomes in this high-risk population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.